Global cardiac assistive medical device prospect analysis
Cardiovascular disease as a major disease will create a market of billions of dollars. The heart disease device is the second largest field of medical devices, second only to IVD. The market size accounts for 11% of the medical device market. Due to the high R&D and academic marketing barriers, the pattern of oligopoly and strong and strong is formed. Among them, in the context of high cardiovascular disease in China, the market demand for cardiovascular interventional devices is huge, and the industry has good development prospects.
First, heart disease has created a global billion-dollar market
For tens of millions of people with global heart disease, especially those at high risk of heart disease, how to reduce heart disease morbidity and mortality through effective interventions has become an increasingly important public health problem. The rapid growth of heart disease patients has brought huge market space for heart disease drugs. According to estimates by Evaluate Med Tech, the global cardiovascular disease drug market reached US$100 billion in 2015, and the device market reached US$43 billion, making it an important area for the distribution of pharmaceutical giants around the world.
Panoramic view of drugs & equipment in the field of heart disease
Second, the heart device: high barriers, strong Hengqiang
In the field of cardiac medical devices, it has been one of the largest segments of the global medical device market. According to the prediction of China Medical and Economic Journal, in 2020, the market for cardiac medical devices accounted for 11% of the global medical device market. The second largest market for in vitro diagnostics.
Forecast of market size of the top 10 sub-sectors in the global medical device market in 2020
According to Evaluate Med Tech, the global cardiac medical device scale will grow from a compound annual growth rate of 36 billion yuan in 2011 to 4 billion yuan in 2018, occupying the market's largest share of high-end interventional supplies and pacemakers. Technical barriers are extremely high, and most SMEs do not have the strength to continue to invest in related fields, resulting in a much higher concentration of the equipment market than the pharmaceutical market. Top10 companies such as Medtronic, St. Jude, Boston Science, and Abbott account for the total market share. 80%, and the industry integration speed is fast, it is expected that the future oligopolistic competition will not change much.
The top ten global cardiovascular equipment scale and sales forecast
Disposable Gel,Moisturizing Hand Sanitizer,Hand Sanitizer,Hand Sanitizer Dispenser
Wuxi Keni Daily Cosmetics Co.,Ltd , https://www.kenidailycosmetics.com